{"changes":[],"country":"US","description":"Early Is Good runs a multi-omic cancer diagnostic platform that simultaneously profiles DNA, RNA, and proteins from blood or urine samples at attomolar sensitivity. Customers are oncologists and patients making biopsy, treatment, and monitoring calls in bladder and prostate cancer. The company closed seed funding in 2022 around the unified single-sample multi-omic readout.","domain":"earlyisgood.com","employees":null,"founded":2022,"fundingTotalQuarantined":false,"githubOrg":null,"githubStars":null,"industry":"unknown","investors":[],"lat":39.768333,"lng":-86.15835,"location":"indianapolis, in, usa","name":"EARLY IS GOOD, INC.","rounds":[{"amountQuarantined":false,"amountUsd":1700000,"currency":"USD","date":"2024-01-01","investors":[],"leadInvestor":null,"source":{"fact":"round","publisher":"sbir","retrievedAt":"2026-05-05","status":"attributed","url":null},"status":"attributed","type":"grant","url":null}],"slug":"earlyisgood-com","sources":[{"fact":"round","publisher":"sbir","retrievedAt":"2026-05-05","status":"attributed","url":null},{"fact":"existence","publisher":"earlyisgood.com","retrievedAt":"2026-05-05","status":"self-reported","url":"https://earlyisgood.com"},{"fact":"description","publisher":"earlyisgood.com","retrievedAt":"2026-05-05","status":"self-reported","url":"https://earlyisgood.com"}],"stage":null,"techStack":["Cloudflare"],"totalRaisedUsd":1700000,"updatedAt":"2026-05-05"}